Praxis Precision Medicines dismisses Ernst & Young, engages KPMG as auditor
Praxis Precision Medicines' Audit Committee approved the dismissal of Ernst & Young LLP as the company's independent registered public accounting firm on June 29, 2026, effective immediately. KPMG LLP was simultaneously engaged as the new auditor. EY's prior audit reports contained no adverse opinions, disclaimers, or qualifications, and the company reported no disagreements or reportable events with EY during fiscal years 2024 and 2025 through the dismissal date.
Key facts
- Ernst & Young LLP dismissed effective June 29, 2026
- KPMG LLP engaged as new auditor effective June 29, 2026
- EY audit reports for fiscal years ended December 31, 2025 and December 31, 2024 contained no adverse opinion, disclaimer, or qualification
- No disagreements with EY on accounting principles, financial disclosure, or audit scope through June 29, 2026
- No reportable events identified during fiscal years 2025, 2024, and through June 29, 2026
Why it matters
The change represents a routine rotation between two Big Four firms with no indication of audit disagreement, financial reporting concern, or going-concern qualification.
Share
Derived from 8-K filed 2026-07-02. Not investment advice. View the source filing on SEC.gov →